Caitong International Asset Management Co., LTD Pacira Bio Sciences, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 2,044 shares of PCRX stock, worth $52,326. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,044Holding current value
$52,326% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding PCRX
# of Institutions
255Shares Held
51.1MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$205 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$134 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$58 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$57.4 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$52.5 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.17B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...